XML 20 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY
9 Months Ended
Dec. 31, 2024
LOSS PER SHARE AND STOCKHOLDERS’ EQUITY [Abstract]  
EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY
2. EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY:
 
Earnings Per Share
 
A reconciliation of the numerator and denominator of basic and diluted earnings per share is shown below (in thousands, except per share amounts):
 
For the three months endedFor the nine months ended
December 31,December 31,
2024202320242023
Basic earnings per share:
Net earnings from continuing operations$9,522 $13,379 $3,765 $16,269 
Earnings from discontinued operations, net of tax1,688 598 1,688 985 
Net earnings$11,210 $13,977 $5,453 $17,254 
Basic weighted-average shares outstanding65,631 65,961 66,182 66,247 
Continuing operations$0.15 $0.20 $0.06 $0.25 
Discontinued operations0.03 0.01 0.03 0.01 
Basic earnings per share:$0.17 $0.21 $0.08 $0.26 
Diluted earnings per share:
Basic weighted-average shares outstanding65,631 65,961 66,182 66,247 
Dilutive effect of common stock options and restricted stock units as computed under the treasury stock method1,112 1,982 1,323 1,486 
Diluted weighted-average shares outstanding66,743 67,943 67,505 67,733 
Continuing operations$0.14 $0.20 $0.06 $0.24 
Discontinued operations0.03 0.01 0.03 0.01 
Diluted earnings per share:$0.17 $0.21 $0.08 $0.25 
Anti-dilutive equity awards under stock-based award plans excluded from the determination of diluted earnings per share826 1,046 2,166 1,065 
Earnings per share totals may not sum due to rounding.


Stockholders’ Equity

On August 14, 2024, the Company's board of directors approved an amendment to the existing common stock repurchase program, which was initially adopted in 2011. The amendment authorized an additional $200.0 million in share repurchases, increasing the total amount authorized for repurchase under the common stock repurchase program to $1.3 billion. In addition, it extended the common stock repurchase program duration through December 31, 2026.

During the nine months ended December 31, 2024, the Company repurchased 2.8 million shares of its common stock for $75.7 million under the modified common stock repurchase program. Through December 31, 2024, the Company had repurchased a total of 40.5 million shares of its common stock for $1.0 billion under the program, leaving remaining capacity of $281.6 million. The repurchase amounts included in the condensed consolidated statements of stockholders' equity include immaterial amounts related to the 1% excise tax on share repurchases, net of share issuances, as a result of the Inflation Reduction Act of 2022 ("IRA").
 
Accumulated other comprehensive income balances of $3.5 million and $4.0 million at December 31, 2024 and March 31, 2024, respectively, reflect accumulated foreign currency translation adjustments.